ClearPoint Neuro, Inc. (CLPT)
9.14
-0.11
(-1.19%)
USD |
NASDAQ |
Oct 23, 16:00
9.14
0.00 (0.00%)
After-Hours: 04:03
ClearPoint Neuro Enterprise Value : 313.38M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 313.38M |
| October 22, 2026 | 316.74M |
| October 21, 2026 | 316.74M |
| October 20, 2026 | 322.84M |
| October 19, 2026 | 314.30M |
| October 16, 2026 | 311.25M |
| October 15, 2026 | 328.63M |
| October 14, 2026 | 316.43M |
| October 13, 2026 | 333.82M |
| October 12, 2026 | 345.71M |
| October 09, 2026 | 354.26M |
| October 08, 2026 | 354.56M |
| October 07, 2026 | 359.75M |
| October 06, 2026 | 370.42M |
| October 05, 2026 | 385.98M |
| October 02, 2026 | 366.91M |
| October 01, 2026 | 383.84M |
| September 30, 2026 | 407.03M |
| September 29, 2026 | 393.60M |
| September 28, 2026 | 501.59M |
| September 25, 2026 | 486.94M |
| September 24, 2026 | 480.23M |
| September 23, 2026 | 491.21M |
| September 22, 2026 | 516.23M |
| September 21, 2026 | 460.71M |
| Date | Value |
|---|---|
| September 18, 2026 | 456.44M |
| September 17, 2026 | 453.70M |
| September 16, 2026 | 443.32M |
| September 15, 2026 | 435.70M |
| September 14, 2026 | 445.15M |
| September 11, 2026 | 453.09M |
| September 10, 2026 | 445.76M |
| September 09, 2026 | 457.97M |
| September 08, 2026 | 463.15M |
| September 04, 2026 | 460.41M |
| September 03, 2026 | 463.15M |
| September 02, 2026 | 471.08M |
| September 01, 2026 | 489.08M |
| August 31, 2026 | 496.40M |
| August 28, 2026 | 508.91M |
| August 27, 2026 | 520.80M |
| August 26, 2026 | 533.92M |
| August 25, 2026 | 551.92M |
| August 24, 2026 | 497.32M |
| August 21, 2026 | 504.03M |
| August 20, 2026 | 497.93M |
| August 19, 2026 | 521.41M |
| August 18, 2026 | 497.62M |
| August 17, 2026 | 507.38M |
| August 14, 2026 | 502.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| SINTX Technologies, Inc. | 10.01M |
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.34M |
| Revenue (Quarterly) | 10.88M |
| Total Expenses (Quarterly) | 22.22M |
| EPS Diluted (Quarterly) | -0.3758 |
| Gross Profit Margin (Quarterly) | 59.79% |
| Profit Margin (Quarterly) | -104.2% |
| Earnings Yield | -12.88% |
| Normalized Earnings Yield | -12.88 |